Search

You searched for "blind"

3643 results found

Haag-Streit UK looks forward to exhibiting at the RCOphth Annual Congress 2023

28 March 2023 | Awards, Conferences & Anniversaries
Haag-Streit UK is pleased to announce it will be exhibiting at Royal College of Ophthalmologists (RCOphth) Annual Congress on 22-25 May 2023 at the ICC in Birmingham.

Théa Pharmaceuticals are excited to be attending RCOphth Congress 2023 with two innovative new products.

22 May 2023 | Research & Development, Awards, Conferences & Anniversaries
This year Théa will also have two stands – one right by the registration desk which will be focused on product sampling and a larger stand inside the main exhibition hall which will showcase the wider product range.

Haag-Streit UK moves to exciting new premises

19 June 2023 | Company Profiles, Research & Development
Haag Streit UK is pleased to announce that we have moved our UK headquarters from Harlow to Bishop’s Stortford.

How I overcame the hurdle that is the FRCOphth Part 1

1 December 2017 | | Cataract and Refractive, Cornea / External Eye Disease, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous, AMD, Emergency Ophthalmology
The FRCOphth Part 1 is one of the most difficult exams in ophthalmology training, with an exam pass rate of 39.6% over the last 12 months (compared to 60.8% for FRCOphth Part 2 oral [60.8%] and written [68.7%]). Stack the...

Introducing Danny Laycock, talent solutions specialist for the ophthalmology sector with a truly global reach

6 July 2023 | Recruitment & Personnel
Is your company changing the future of Ophthalmics? We’re collating a list of the top companies to watch in the space for 2024.

PUK after corneal crosslinking

1 April 2019 | | Cornea / External Eye Disease
This retrospective study aimed to report the incidence, characteristics, clinical presentations, risk factors, and the available treatment modalities of sterile peripheral ulcerative keratitis (PUK) post-corneal collagen crosslinking (CXL). In total 771 eyes of 474 patients operated for keratoconus or ectasia...

Scope Ophthalmology announce case awards winners

11 September 2023 | Awards, Conferences & Anniversaries
Scope Eyecare are delighted to announce the winners of the Scope Ophthalmology case awards UK and Ireland for 2023.

Haag-Streit UK appoints a new Regional Sales Manager

12 October 2023 | Recruitment & Personnel, Company Profiles
Haag Streit UK is pleased to announce the appointment of Martin Rescorle in the role of Regional Sales Manager.

BELKIN Vision is pleased to announce FDA clearance for its glaucoma laser, the Eagle device

14 December 2023 | SLT, DSLT, the eagle, Belkin, Glaucoma, Laser therapy, USA
BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.

Ophthalmic Drugs Conference 2020

23 November 2020 -24 November 2020
SMi proudly presents the 4th Annual Ophthalmic Drugs Conference taking place on 23-24 November 2020, in London.

Principles of management

1 August 2016 | | Cataract and Refractive, Cornea / External Eye Disease, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous, AMD, Emergency Ophthalmology
Whatever section of pathology is to blame and wherever it strikes, the aim of treatment is always the same. Find the cause if you can. Establish the effects of the cause. Halt the pathological process if you can. Reverse its...

A career in uveitis

7 December 2020 | | Ophthalmology, Retina / Uvea / Vitreous
As he retires from clinical practice, the author looks back on his long career in uveitis and how care of these patients has changed dramatically since his days as an undergraduate. My trainees and fellows are often bored by my...